Targets for current pharmacologic therapy in cholesterol gallstone disease.
about
Gallstones: new insights into an old storyA novel therapeutic effect of statins on nephrogenic diabetes insipidusEzetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver diseaseTherapy of gallstone disease: What it was, what it is, what it will beEffect of ursodeoxycholic Acid alone and ursodeoxycholic Acid plus domperidone on radiolucent gallstones and gallbladder contractility in humansMolecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Antilithiasic and hypolipidaemic effects of Raphanus sativus L. var. niger on mice fed with a lithogenic diet.Effects of sphincter of Oddi motility on the formation of cholesterol gallstones.Organochloride pesticides induced hepatic ABCG5/G8 expression and lipogenesis in Chinese patients with gallstone disease.High rates of recurrent biliary tract obstruction in children with sickle cell disease.Raphanus sativus L. var niger as a source of phytochemicals for the prevention of cholesterol gallstones.Management of gallstones and its related complications.Declining cholecystectomy rate during the era of statin use in Finland: a population-based cohort study between 1995 and 2009.Effects of Korean red ginseng as an adjuvant to bile acids in medical dissolution therapy for gallstones: a prospective, randomized, controlled, double-blind pilot trial.Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease.Statin use and the risk of gallstone disease: a population-based case-control study.Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.Recent advances in understanding and managing cholesterol gallstones
P2860
Q26742042-C82809F3-CCC0-4013-B00E-0DEB87C79722Q27005638-EA3D8585-2F8A-40A6-9DA5-9FA9A9C29796Q35550630-73F08BED-1381-4AC6-B97B-E65C278959E6Q35948819-7FCEBFD8-9DF1-4095-8D8C-29BB5FF58857Q35960449-615AE398-077E-4D0A-A426-5E6D866D6E86Q36197335-EF916C37-A33E-4F30-AE97-C4EE56D9AB6BQ36316329-C6C64CA9-6CF7-40D5-9460-5D43A3A6C0F3Q37030194-58FA331C-8639-4948-AC53-F219F6F838A7Q37376131-40AD91FB-AC0D-4BB6-9342-BB9ECE956587Q37687064-03B7838E-D1B6-4E80-90FE-82D57B142743Q38089706-346E3196-3A3D-4E96-9E5F-BD3DAF230BE1Q38631199-0C74E075-946C-4DAF-881C-554B4346E59FQ42614756-949A451D-6E70-49CF-979A-A741FD32FDAAQ44749596-F92EDC86-1D80-4309-BDA5-9E58DF0F3A43Q50150874-D1E44AEC-DC9B-402B-940C-361F72E032F1Q50153986-A260646B-FA48-42E4-B7DE-97417A948953Q50189827-55FD95E6-D413-461D-A110-0EDF9C29DA1CQ57821646-3FD69C97-D332-44D5-8E40-F57F7C78BCAA
P2860
Targets for current pharmacologic therapy in cholesterol gallstone disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@ast
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@en
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@nl
type
label
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@ast
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@en
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@nl
prefLabel
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@ast
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@en
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@nl
P2093
P2860
P1476
Targets for current pharmacologic therapy in cholesterol gallstone disease.
@en
P2093
David Q H Wang
Helen H Wang
Leonilde Bonfrate
P2860
P304
245-64, viii-ix
P356
10.1016/J.GTC.2010.02.005
P577
2010-06-01T00:00:00Z